Open Access
ARTICLE
The role of HBD-2, HBD-3, and calprotectin in the relationship between chronic periodontitis and atherosclerosis
MEHMET TASPINAR1,2,*, ALIHAN BOZOGLAN3,4, ABDULLAH SECKIN ERTUGRUL5, LEVENT ELMAS6
1 Faculty of Medicine, Aksaray University, Aksaray, Turkey
2 Faculty of Medicine, Yuzuncu Yil University, Van, Turkey
3 Department of Periodontology, Faculty of Dentistry, Fırat University, Elazığ, Turkey
4 Department of Periodontology, Faculty of Dentistry, Yuzuncu Yil University, Van, Turkey
5 Department of Periodontology, Faculty of Dentistry, İzmir Katip Çelebi University, İzmir, Turkey 6 Faculty of Medicine, Pamukkale University, Denizli, Turkey
* Address correspondence to: Mehmet Taspinar,
(This article belongs to the Special Issue: Stem Cells, Protein Therapeutics, and Regenerative Medicine)
BIOCELL 2020, 44(3), 337-344. https://doi.org/10.32604/biocell.2020.011470
Received 10 May 2020; Accepted 10 June 2020; Issue published 22 September 2020
Abstract
This study was carried out to compare individuals diagnosed with atherosclerosis and periodontal periodontitis
based on the degree of change in the human beta-defensins (HBD) HBD-2, HBD-3, and calprotectin. Atherosclerosis is
the most frequently observed cardiovascular disease. Dental and periodontal infections are known to provide a
considerable basis for atheroma plaque formation. The study group consists of a total number of 40 subjects, with 20
patients diagnosed with atherosclerosis and chronic periodontitis and 20 systemically healthy patients diagnosed with
chronic periodontitis. Clinical periodontal and blood parameters and HBD-2, HBD-3, and calprotectin biomarkers in
the gingival crevicular fluid were measured. In both groups, following clinical periodontal treatment, a statistically
significant decrease in white blood cells (WBC), low-density lipoproteins (LDL), fibrinogen, creatinine, and platelets
(PLT), a statistically significant increase in high-density lipoproteins (HDL) in blood samples, statistically meaningful
decrease in HBD-2, HBD-3, and calprotectin in the gingival crevicular fluid were achieved. Blood values and HBD-2,
HBD-3, calprotectin amounts in the gingival crevicular fluid were increased significantly in the test group compared
to the control group. A positive correlation was observed between decreases in HBD-2, HBD-3, calprotectin, and
clinical periodontal indices. Regression in systemic inflammation was observed after clinical periodontal treatment. It
is concluded that nonsurgical periodontal treatment of chronic periodontitis positively affects atherosclerosis prognosis.
Keywords
Cite This Article
APA Style
TASPINAR, M., BOZOGLAN, A., ERTUGRUL, A.S., ELMAS, L. (2020). The role of HBD-2, HBD-3, and calprotectin in the relationship between chronic periodontitis and atherosclerosis. BIOCELL, 44(3), 337-344. https://doi.org/10.32604/biocell.2020.011470
Vancouver Style
TASPINAR M, BOZOGLAN A, ERTUGRUL AS, ELMAS L. The role of HBD-2, HBD-3, and calprotectin in the relationship between chronic periodontitis and atherosclerosis. BIOCELL . 2020;44(3):337-344 https://doi.org/10.32604/biocell.2020.011470
IEEE Style
M. TASPINAR, A. BOZOGLAN, A.S. ERTUGRUL, and L. ELMAS "The role of HBD-2, HBD-3, and calprotectin in the relationship between chronic periodontitis and atherosclerosis," BIOCELL , vol. 44, no. 3, pp. 337-344. 2020. https://doi.org/10.32604/biocell.2020.011470
Citations